Literature DB >> 32457476

Cancer cell therapies: the clinical trial landscape.

Jia Xin Yu, Samik Upadhaya, Revati Tatake, Fern Barkalow, Vanessa M Hubbard-Lucey.   

Abstract

Entities:  

Year:  2020        PMID: 32457476     DOI: 10.1038/d41573-020-00099-9

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  26 in total

Review 1.  Navigating CAR-T cells through the solid-tumour microenvironment.

Authors:  Andrew J Hou; Laurence C Chen; Yvonne Y Chen
Journal:  Nat Rev Drug Discov       Date:  2021-05-10       Impact factor: 84.694

2.  Pharmacogenomics for immunotherapy and immune-related cardiotoxicity.

Authors:  Jessica A Castrillon; Charis Eng; Feixiong Cheng
Journal:  Hum Mol Genet       Date:  2020-10-20       Impact factor: 6.150

Review 3.  Industrializing engineered autologous T cells as medicines for solid tumours.

Authors:  Cedrik M Britten; Aiman Shalabi; Axel Hoos
Journal:  Nat Rev Drug Discov       Date:  2021-04-08       Impact factor: 84.694

4.  Adoptive T-cell Immunotherapy: Perfecting Self-Defenses.

Authors:  Raphaëlle Toledano Zur; Galit Adler; Katerina Shamalov; Yair Tal; Chen Ankri; Cyrille J Cohen
Journal:  Exp Suppl       Date:  2022

Review 5.  How Do We Meet the Challenge of Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors?

Authors:  Adam J Schoenfeld; Roisin E O'Cearbhaill
Journal:  Cancer J       Date:  2021 Mar-Apr 01       Impact factor: 3.360

Review 6.  An overview of CAR T-cell clinical trial activity to 2021.

Authors:  Antonella Adami; John Maher
Journal:  Immunother Adv       Date:  2021-03-09

7.  Single-cell multiomics dissection of basal and antigen-specific activation states of CD19-targeted CAR T cells.

Authors:  J Joseph Melenhorst; Rong Fan; Zhiliang Bai; Stefan Lundh; Dongjoo Kim; Steven Woodhouse; David M Barrett; Regina M Myers; Stephan A Grupp; Marcela V Maus; Carl H June; Pablo G Camara
Journal:  J Immunother Cancer       Date:  2021-05       Impact factor: 13.751

8.  Single Cell Technologies to Dissect Heterogenous Immune Cell Therapy Products.

Authors:  Katherine Mueller; Krishanu Saha
Journal:  Curr Opin Biomed Eng       Date:  2021-09-15

9.  Comparative analysis of cell therapy infusion workflows at clinical sites.

Authors:  Adam Joules; Julianne Connors; Rachel Johnson; Elizabeth A Van Orsow; David H McKenna; Sarah Nikiforow; Jerome Ritz; Adrian Gee; Allison Hubel
Journal:  Cytotherapy       Date:  2021-01-30       Impact factor: 6.196

10.  Adoptive cell therapy: Living drugs against cancer.

Authors:  Tamara Laskowski; Katayoun Rezvani
Journal:  J Exp Med       Date:  2020-12-07       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.